# Taro Pharmaceutical Industries Ltd. (TARO)

Source: https://www.quantisnow.com/company/TARO
Generated: 2026-11-18T01:14:37.384Z

- Ticker: TARO
- Exchange: NYSE
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- Website: taro.com

## About

Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprises allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, and other direct purchasers and customers, as well as healthcare institutions and private pharmacies. The company was founded in 1950 and is based in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.

## Latest TARO news and filings

- 2024-07-05 15:25 UTC [SEC Form 15F-12B filed by Taro Pharmaceutical Industries Ltd.](https://www.quantisnow.com/insight/sec-form-15f-12b-filed-by-taro-pharmaceutical-industries-ltd-5595167)
- 2024-06-24 14:01 UTC [SEC Form 25-NSE filed by Taro Pharmaceutical Industries Ltd.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-taro-pharmaceutical-industries-ltd-5572923)
- 2024-06-24 11:47 UTC [Sun Pharma Completes Taro Merger](https://www.quantisnow.com/insight/sun-pharma-completes-taro-merger-5572392)
- 2024-06-24 11:27 UTC [SEC Schedule 13D] [Amendment: SEC Form SC 13D/A filed by Taro Pharmaceutical Industries Ltd.](https://www.quantisnow.com/insight/amendment-sec-form-sc-13da-filed-by-taro-pharmaceutical-industries-5572317)
- 2024-06-24 11:09 UTC [Amendment: SEC Form SC 13E3/A filed by Taro Pharmaceutical Industries Ltd.](https://www.quantisnow.com/insight/amendment-sec-form-sc-13e3a-filed-by-taro-pharmaceutical-industries-5572277)
- 2024-06-24 10:45 UTC [SEC Form 6-K] [SEC Form 6-K filed by Taro Pharmaceutical Industries Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-taro-pharmaceutical-industries-ltd-5572188)
- 2024-05-23 12:01 UTC [SEC Form SC 13E3/A filed by Taro Pharmaceutical Industries Ltd. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13e3a-filed-by-taro-pharmaceutical-industries-ltd-5512261)
- 2024-05-23 11:56 UTC [Market Chatter] [Sun Pharmaceutical And Taro Pharmaceutical Industries' Merger Agreement Was Approved By The Affirmative Vote Of Taro Shareholders](https://www.quantisnow.com/insight/sun-pharmaceutical-and-taro-pharmaceutical-industries-merger-agreement-was-approved-5512167)
- 2024-05-23 11:50 UTC [Taro Shareholders Approve Merger with Sun Pharma](https://www.quantisnow.com/insight/taro-shareholders-approve-merger-with-sun-pharma-5512152)
- 2024-05-23 11:30 UTC [SEC Form 6-K] [SEC Form 6-K filed by Taro Pharmaceutical Industries Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-taro-pharmaceutical-industries-ltd-5512080)
- 2024-05-21 13:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by Taro Pharmaceutical Industries Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-taro-pharmaceutical-industries-ltd-5506350)
- 2024-05-20 21:16 UTC [Market Chatter] [Taro Pharmaceutical Indus Q4 Adj EPS $0.43 Beats $0.31 Estimate, Sales $164.941M Beat $156.062M Estimate](https://www.quantisnow.com/insight/taro-pharmaceutical-indus-q4-adj-eps-043-beats-031-estimate-5504911)
- 2024-05-20 21:00 UTC [Taro Provides Results for Year Ended March 31, 2024](https://www.quantisnow.com/insight/taro-provides-results-for-year-ended-march-31-2024-5504750)
- 2024-05-15 13:00 UTC [Taro to Release Full Year Results on May 20, 2024](https://www.quantisnow.com/insight/taro-to-release-full-year-results-on-may-20-2024-5491818)
- 2024-05-14 12:20 UTC [SEC Form SC 13E3/A filed by Taro Pharmaceutical Industries Ltd. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13e3a-filed-by-taro-pharmaceutical-industries-ltd-5487549)
- 2024-05-08 13:28 UTC [SEC Form SC 13E3/A filed by Taro Pharmaceutical Industries Ltd. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13e3a-filed-by-taro-pharmaceutical-industries-ltd-5470635)
- 2024-05-08 13:07 UTC [Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote "FOR" Taro Sun Pharma Merger](https://www.quantisnow.com/insight/leading-independent-proxy-advisory-firms-iss-and-glass-lewis-recommend-5470538)
- 2024-04-15 12:00 UTC [Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.](https://www.quantisnow.com/insight/taro-announces-extraordinary-general-meeting-and-ordinary-class-meeting-of-5409521)
- 2024-04-15 10:07 UTC [SEC Form SC 13E3/A filed by Taro Pharmaceutical Industries Ltd. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13e3a-filed-by-taro-pharmaceutical-industries-ltd-5409165)
- 2024-03-20 20:32 UTC [SEC Form SC 13E3/A filed by Taro Pharmaceutical Industries Ltd. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13e3a-filed-by-taro-pharmaceutical-industries-ltd-5358591)
- 2024-03-11 10:19 UTC [SEC Form SC 13E3/A filed by Taro Pharmaceutical Industries Ltd. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13e3a-filed-by-taro-pharmaceutical-industries-ltd-5332126)
- 2024-02-15 13:36 UTC [SEC Form SC 13E3 filed by Taro Pharmaceutical Industries Ltd.](https://www.quantisnow.com/insight/sec-form-sc-13e3-filed-by-taro-pharmaceutical-industries-ltd-5266776)
- 2024-01-30 12:07 UTC [Market Chatter] [Krensavage Asset Management Remains Opposed to Sun Pharma's Predatory Bid for Taro Pharma](https://www.quantisnow.com/insight/krensavage-asset-management-remains-opposed-to-sun-pharmas-predatory-bid-5215670)
- 2024-01-30 12:00 UTC [Krensavage Asset Management Remains Opposed to Sun's Predatory Bid for Taro](https://www.quantisnow.com/insight/krensavage-asset-management-remains-opposed-to-suns-predatory-bid-for-5215604)
- 2024-01-26 14:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by Taro Pharmaceutical Industries Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-taro-pharmaceutical-industries-ltd-5209863)
- 2024-01-25 22:07 UTC [Market Chatter] [Taro Pharmaceutical Indus Q3 2024 GAAP EPS $0.54 Beats $0.30 Estimate](https://www.quantisnow.com/insight/taro-pharmaceutical-indus-q3-2024-gaap-eps-054-beats-030-5208944)
- 2024-01-25 22:07 UTC [Market Chatter] [Taro Pharmaceutical Indus Q3 Sales $157.10M Beat $154.91M Estimate](https://www.quantisnow.com/insight/taro-pharmaceutical-indus-q3-sales-15710m-beat-15491m-estimate-5208942)
- 2024-01-25 22:06 UTC [Taro Provides Results for December 31, 2023](https://www.quantisnow.com/insight/taro-provides-results-for-december-31-2023-5208933)
- 2024-01-25 10:51 UTC [Market Insight] [Earnings Scheduled For January 25, 2024](https://www.quantisnow.com/insight/earnings-scheduled-for-january-25-2024-5205962)
- 2024-01-24 19:01 UTC [Market Insight] [Earnings Preview For Taro Pharmaceutical Indus](https://www.quantisnow.com/insight/earnings-preview-for-taro-pharmaceutical-indus-5204332)
- 2024-01-19 21:15 UTC [Earnings Date] [Taro to Release Third Quarter Results on January 25, 2024](https://www.quantisnow.com/insight/taro-to-release-third-quarter-results-on-january-25-2024-5196439)
- 2024-01-18 12:15 UTC [Analyst Downgrade] [Taro Pharm downgraded by H.C. Wainwright with a new price target](https://www.quantisnow.com/insight/taro-pharm-downgraded-by-hc-wainwright-with-a-new-price-5192777)
- 2024-01-18 11:15 UTC [Market Chatter] [HC Wainwright & Co. Downgrades Taro Pharmaceutical Indus to Neutral, Maintains Price Target to $43](https://www.quantisnow.com/insight/hc-wainwright-co-downgrades-taro-pharmaceutical-indus-to-neutral-maintains-5192607)
- 2024-01-17 21:36 UTC [SEC Form 6-K] [SEC Form 6-K filed by Taro Pharmaceutical Industries Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-taro-pharmaceutical-industries-ltd-5191747)
- 2024-01-17 21:35 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Taro Pharmaceutical Industries Ltd. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-taro-pharmaceutical-industries-ltd-5191739)
- 2024-01-17 21:32 UTC [Market Chatter] [Taro Pharmaceutical Entered Into Definitive Merger Agreement With Sun Pharma; Sun Pharma To Acquire All Taro's Outstanding Ordinary Shares Of Taro For $43/Share](https://www.quantisnow.com/insight/taro-pharmaceutical-entered-into-definitive-merger-agreement-with-sun-pharma-5191692)
- 2024-01-17 21:30 UTC [Taro Announces Merger Agreement with Sun Pharma](https://www.quantisnow.com/insight/taro-announces-merger-agreement-with-sun-pharma-5191643)
- 2024-01-04 21:30 UTC [SEC Form 6-K] [SEC Form 6-K filed by Taro Pharmaceutical Industries Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-taro-pharmaceutical-industries-ltd-5170172)
- 2023-12-11 21:31 UTC [SEC Form 6-K] [SEC Form 6-K filed by Taro Pharmaceutical Industries Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-taro-pharmaceutical-industries-ltd-5130551)
- 2023-12-11 21:30 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Taro Pharmaceutical Industries Ltd. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-taro-pharmaceutical-industries-ltd-5130546)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/TARO
- Earnings history: https://www.quantisnow.com/earnings/TARO
- Dividend history: https://www.quantisnow.com/dividends/TARO
- Insider transactions: https://www.quantisnow.com/insiders/TARO
- Options chain: https://www.quantisnow.com/options/TARO
- SEC 8-K filings only: https://www.quantisnow.com/company/TARO/8-k
- RSS and alerts for TARO: https://www.quantisnow.com/docs/rss-feeds.md
